Cite
KAN0438757, a novel PFKFB3 inhibitor, prevent the progression of severe acute pancreatitis via the Nrf2/HO-1 pathway in infiltrated macrophage.
MLA
Ergashev, Akmal, et al. “KAN0438757, a Novel PFKFB3 Inhibitor, Prevent the Progression of Severe Acute Pancreatitis via the Nrf2/HO-1 Pathway in Infiltrated Macrophage.” Free Radical Biology & Medicine, vol. 210, Jan. 2024, pp. 130–45. EBSCOhost, https://doi.org/10.1016/j.freeradbiomed.2023.11.010.
APA
Ergashev, A., Shi, F., Liu, Z., Pan, Z., Xie, H., Kong, L., Wu, L., Sun, H., Jin, Y., Kong, H., Geng, D., Ibrohimov, A., Obeng, E., Wang, Y., Ma, F., Chen, G., & Zhang, T. (2024). KAN0438757, a novel PFKFB3 inhibitor, prevent the progression of severe acute pancreatitis via the Nrf2/HO-1 pathway in infiltrated macrophage. Free Radical Biology & Medicine, 210, 130–145. https://doi.org/10.1016/j.freeradbiomed.2023.11.010
Chicago
Ergashev, Akmal, Fengyu Shi, Zhu Liu, Zhenyan Pan, Haonan Xie, Lingming Kong, Lijun Wu, et al. 2024. “KAN0438757, a Novel PFKFB3 Inhibitor, Prevent the Progression of Severe Acute Pancreatitis via the Nrf2/HO-1 Pathway in Infiltrated Macrophage.” Free Radical Biology & Medicine 210 (January): 130–45. doi:10.1016/j.freeradbiomed.2023.11.010.